Page 155 - Revol6

Tomas Sánchez-Araña, M.ª Luz Torralba, M.ª José Montoya, M.ª Carmen Gómez y Rafael Touriño
119. Ryan MC , Thakore JH. Physical consequences of schizophrenia
and its treatment: the metabolic syndrome. Life Scie 2002; 71:
239-57.
120. Saari KM, Lindeman SM, Viilo KM, Isohanni MK, Jarvelin
MR, Lauren LH, Savolainen MJ, Koponen HJ. A 4-fold risk of
metabolic syndrome in patients with schizophrenia: the
Northern Finland 1966 Birth Cohort study.J Clin Psychiatry.
2005; 66 (5): 559-63.
121. Saari K, Jokelainen J, Veijola J, Koponen H, Jones PB,
Savolainen M, Jarvelin MR, Lauren L, Isohanni M, Lindeman S.
Serum lipids in schizophrenia and other functional psychoses: a
general population northern Finland 1966 birth cohort survey.
Acta Psychiatr Scand. 2004; 110 (4): 279-85.
122. Sacks FM. Metabolic syndrome: epidemiology and consequen-
ces. J Clin Psychiatry. 2004; 65 (Suppl 18): 3-12.
123. Sánchez PM, Gutiérrez M, Segarra R, González A. Efectos
secundarios extrapiramidales de los fármacos antipsicóticos.
Actas Esp Psiquiatr 2001; 29 (Suppl 1): 17-35.
124. Sánchez-Araña T, Touriño González R, Hernández Fleta JL,
León Pérez P. Alta prevalencia de síndrome metabólico en
pacientes esquizofrénicos: una revisión de la literatura. Psiq
Biol. 2006; 13 (4): 127-35.
125. Schoos R, Cohen CI: Medical comorbidity in older schizophre-
nic person. En Schizophrenia Into Later Life. Edited by Cohen
CI. Washington, DC, American Psychiatric Publishing, 2003.
126. Shriqui CL, Annable L. Discinesia Tardía. En: Shriqui Cl,
Nasrallah HA (eds). Aspectos actuales en el Tratamiento de la
Esquizofrenia. Madrid: Editores Médicos 1996. Pág: 665-718.
127. Sox HC Jr, Koran LM, Sox CH, Marton KI, Dugger F, Smith T.
A medical algorithm for detecting physical disease in psychia-
tric patients. Hosp Community Psychiatry. 1989; 40 (12):
1270-6.
128. Strassnig M, Brar JS, Ganguli R. Nutricional assessment of
patients with schizophrenia: a preliminary study. Schizphr Bull.
2003b; 29: 393-7.
129. Stroup TS, Morrissey JP,: System of care for persons with schi-
zophrenia in different countries. En: Lieberman JA, Murray RM
(eds). Comprehensive Care of Schizophrenia: A Textbook of
162 Evaluación en Rehabilitación Psicosocial
Clinical Management. Edited by. London, Martin Dunitz;
2001, Pág: 315-26.
130. Taylor D, Young C, Mohamed R, Paton C, Walwyn R.
Undiagnosed impaired fasting glucose and diabetes mellitus
amongst inpatients receiving antipsychotic drugs. J
Psychopharmacol. 2005; 19 (2):182-6.
131. Thakore JH. Metabolic syndrome and schizophrenia. Br J
Psychiatry 2005, 186: 455-6.
132. Thakore JH. Metabolic disturbance in first-episode schizophre-
nia. Br J Psychiatry Suppl. 2004; 47: 76-9.
133. Thakore JH, Mann JN, Vlahos I, Martin A, Reznek R.
Increased visceral fat distribution in drug-naive and drug-free
patients with schizophrenia. Int J Obes Relat Metab Disord.
2002; 26 (1): 137-41.
134. Vieweg V, Levenson J, Pandurangi A, Silverman J. Medical
disorders in the schizophrenic patient. Int J Psychiatry Med.
1995; 25(2): 137-72.
135. Waddington JL, Youssef HA, Kinsella A. Mortality in schi-
zophrenia. Antipsychotic polipharmacy and absence of anticho-
linergics over the course of a 10-year prospective study. Br J
Psychiatry 1998; 173: 325-9.
136. Walkup J, Satriano J, Hansell S, el al. Practices related lo HIV
risk assessment in general hospital psychiatric units in New
York State. Psychiatr Serv 1998; 49: 529-30.
137. Weinhardt LS, Carey MP, Carey KB. HIV-risk behavior and the
public health context of HIV/AIDS among women living with
a severe and persistent mental illness. J Nerv Ment Dis
1998;186: 276-82.
138. Wirshing DA. Schizophrenia and obesity: impact of antipsy-
chotic medications. J Clin Psychiatry. 2004; 65 (Suppl 18): 13-
26.
139. Yassa R, Mohelsky H, Dimitri R. Mortality rate in tardive dys-
kinesia. Am J Psychiatry 1984; 141: 1018-9.
140. Zhang ZJ, Yao ZJ, Liu W, Fang Q, Reynolds GP.Effects of
antipsychotics on fat deposition and changes in leptin and insu-
lin levels. Magnetic resonance imaging study of previously
untreated people with schizophrenia.Br J Psychiatry. 2004;
184: 58-62.